logo
Select company
Select metric
$ 1.11MNet Cash Flow - Financing
VS
Market
44
Sector
63
Industry
74
History
77
$ 2.5Close
$ 1.36 - $ 2.99 52-Week Range
Ticker Information

Ticker

IMMX

Company Name

IMMIX BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMIX BIOPHARMA INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMMX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 1.11M
3/31/2025$ 0
12/31/2024$ 15.95M
9/30/2024$ 16.54M
6/30/2024$ 26.6M
3/31/2024$ 31.29M
12/31/2023$ 15.46M
9/30/2023$ 15.3M
6/30/2023$ 5.23M
3/31/2023$ 437.23K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMMIX BIOPHARMA INC's latest trailing twelve months (TTM) CF - Financing stands at $ 0.
  • Over the past 5 years, IMMIX BIOPHARMA INC's average CF - Financing has been $ 12.25M.
  • The median CF - Financing for IMMIX BIOPHARMA INC during this period was $ 15.38M
  • IMMIX BIOPHARMA INC reached its highest CF - Financing over the past 5 years at $ 31.29M.
  • The lowest CF - Financing recorded by IMMIX BIOPHARMA INC in the same timeframe $ 0

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

IMMX - Net Cash Flow - Financing, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 31.29M

Maximum

Mar 31, 2024

$ 12.25M

Average

$ 15.38M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M